News Releases

Andrea Kondracke, M.D., Named Director of New Division of Psychiatry and Medicine
Majority of Cancer Patients with COVID-19 Have Similar Immune Response to People Without Cancer
Brendon Stiles, M.D., Named Chief of Thoracic Surgery & Surgical Oncology at Montefiore and Albert Einstein College of Medicine

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Milan Kinkhabwala

Milan Kinkhabwala, M.D.

Area(s) of expertise: Liver diseasesTransplantationStem cell research

Dr. Kinkhabwala is an active member of Einstein’s NIH-funded Marion Bessin Liver Research Center, where he is working to develop new treatments derived from stem cells for liver diseases, including liver cancer. An… Learn more

Einstein in the News

USA Today
Why Do Children Fare Better Than Adults Against COVID-19?

Betsy Herold, M.D., comments on her study establishing, for the first time, that children mount a stronger innate immune response than adults to the virus that causes COVID-19. Dr. Herold is chief of pediatric infectious diseases and vice chair for pediatrics research at Einstein and Children's Hospital at Montefiore and the Harold and Muriel Block Chair in Pediatrics at Einstein.

Additional coverage includes News12

More coverage on Dr. Herold

Bronx Times
Einstein Medical Students Celebrate Match Day

Allison Ludwig, M.D., talks about Einstein's Match Day success in the face of challenges from the COVID-19 pandemic, and fourth-year student Veronica Ortiz recounts her medical school journey and successful match to a pediatrics residency. Dr. Ludwig is associate dean for student affairs, associate professor of medicine at Einstein, and a hospitalist at Jacobi.

Science News
New Drugs That Block a Brain Chemical Are Game Changers for Some Migraine Sufferers

Richard Lipton, M.D., discusses the use of a newer class of migraine drugs known as gepants, which target a neurotransmitter implicated in migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.

More coverage on Dr. Lipton


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog